Fulgent Genetics Inc expected to post a loss of 29 cents a share - Earnings Preview

Fulgent Genetics

26/02/2024 14:36

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
28 for the period ending December 31 2023
    * The El Monte California-based  company is expected to
report a
2.0% decrease in revenue to $66.322 million from $67.7 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data. (Sale majority is on total revenue basis)
    * ​LSEG's mean analyst estimate for Fulgent Genetics Inc is
for a
loss of 29 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $35.00​, above​ its last closing price of $24.06. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.35       -0.33      -0.39     Missed  -18.2
 Jun. 30 2023  -0.33       -0.33      -0.08     Beat    75.6
 Mar. 31 2023  -0.43       -0.43      -0.22     Beat    48.4​
 Dec. 31 2022  -0.56       -0.56      -0.48     Beat    14.3
 ​​Sep.        0.05        0.05       0.32      Beat    498.1
 30 2022                                                
 Jun. 30 2022  0.73        0.73       0.78      Beat    6.8​
 Mar. 31 2022  3.84        3.86       5.08      Beat    31.6
 Dec. 31 2021  2.61        2.61       3.34      Beat    28.1
 This summary was machine generated February 26 at 14:36 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)